Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates.

about

Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates.

Item

http://www.wikidata.org/entity/Q49191669

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Marked elevation of serum lact ...... cal and prognostic correlates.

@en

Marked elevation of serum lact ...... cal and prognostic correlates.

@nl

type

Item

label

Marked elevation of serum lact ...... cal and prognostic correlates.

@en

Marked elevation of serum lact ...... cal and prognostic correlates.

@nl

prefLabel

Marked elevation of serum lact ...... cal and prognostic correlates.

@en

Marked elevation of serum lact ...... cal and prognostic correlates.

@nl

P1476

Marked elevation of serum lact ...... cal and prognostic correlates.

@en

P2093

Animesh Pardanani

http://www.w3.org/2001/XMLSchema#string

Curtis A Hanson

http://www.w3.org/2001/XMLSchema#string

Mythri Mudireddy

http://www.w3.org/2001/XMLSchema#string

Naseema Gangat

http://www.w3.org/2001/XMLSchema#string

Rhett P Ketterling

http://www.w3.org/2001/XMLSchema#string

Sahrish Shah

http://www.w3.org/2001/XMLSchema#string

P2860

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenase.

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.

Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.

Serum lactic dehydrogenase activity in myeloproliferative and lymphoproliferative disorders.

Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons.

The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia.

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.

Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?

P2888

s41408-017-0024-9

P304

657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41408-017-0024-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ayalew Tefferi

P577

2017-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099686650

http://www.w3.org/2001/XMLSchema#string

P698

29249804

http://www.w3.org/2001/XMLSchema#string

P932

5802557

http://www.w3.org/2001/XMLSchema#string